These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26997152)

  • 1. Imaging Agents in Targeting Tumor Hypoxia.
    Zeng Y; Ma J; Zhang S; Wu D
    Curr Med Chem; 2016; 23(17):1775-800. PubMed ID: 26997152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on radionuclide labeled hypoxia-imaging agents.
    Li Z; Chu T
    Curr Pharm Des; 2012; 18(8):1084-97. PubMed ID: 22272826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging of intratumoral hypoxia.
    Foo SS; Abbott DF; Lawrentschuk N; Scott AM
    Mol Imaging Biol; 2004; 6(5):291-305. PubMed ID: 15380739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.
    Subasinghe SAAS; Pautler RG; Samee MAH; Yustein JT; Allen MJ
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospect of hypoxia imaging of nuclear medicine in tumors].
    Chen G; Wang RF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):335-inside back cover. PubMed ID: 16778985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of hypoxia with radiolabelled agents.
    Mees G; Dierckx R; Vangestel C; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1674-86. PubMed ID: 19565239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design strategy of optical probes for tumor hypoxia imaging.
    Xue F; Chen J; Chen H
    Sci China Life Sci; 2020 Dec; 63(12):1786-1797. PubMed ID: 32146696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor hypoxia imaging.
    Sun X; Niu G; Chan N; Shen B; Chen X
    Mol Imaging Biol; 2011 Jun; 13(3):399-410. PubMed ID: 20838906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
    Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional imaging insights into the role of hypoxia in cancer aggression.
    Kakkad S; Krishnamachary B; Jacob D; Pacheco-Torres J; Goggins E; Bharti SK; Penet MF; Bhujwalla ZM
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):51-64. PubMed ID: 30840168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography.
    McConathy J; Goodman MM
    Cancer Metastasis Rev; 2008 Dec; 27(4):555-73. PubMed ID: 18648909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide Reporter Imaging to Visualize Tumor Hypoxia Ex Vivo and In Vivo.
    Inubushi M; Takeuchi Y; Kitagawa Y
    Methods Mol Biol; 2024; 2755():107-123. PubMed ID: 38319572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled glucose derivatives for tumor imaging using SPECT and PET.
    Liu T; Zhang J; Wang X; Yang J; Tang Z; Lu J
    Curr Med Chem; 2014; 21(1):24-34. PubMed ID: 23992343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a method of high-contrasted nuclear medical imaging of hypoxia-inducible factor-1-active tumor by using a pretargeting approach].
    Ueda M
    Yakugaku Zasshi; 2012; 132(5):595-600. PubMed ID: 22687695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
    Sharkey RM; Karacay H; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5577s-5585s. PubMed ID: 17875792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives.
    Niccoli Asabella A; Di Palo A; Altini C; Ferrari C; Rubini G
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Players of 'hypoxia orchestra' - what is the role of FMISO?
    Toyonaga T; Hirata K; Shiga T; Nagara T
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1679-1681. PubMed ID: 28634683
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular Imaging of Pancreatic Cancer with Antibodies.
    England CG; Hernandez R; Eddine SB; Cai W
    Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
    Mortensen LS; Buus S; Nordsmark M; Bentzen L; Munk OL; Keiding S; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):934-40. PubMed ID: 20831480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.